A successful MOMENTUM symposium

Only one week left to register !

ART-TG at the 2024 ESGCT Spring School

ART-TG at Congres France Bioproduction

ART-TG is on Linkedin

All the best for 2024 !

Thérapies géniques, l’espoir fait revivre.

ART-TG recruits - See new job offers

Microsymposium T2 EVOLVE FRANCE

New review: Gene therapy for infectious diseases

Importance to standardize genomic data analysis in gene therapy.

International excellence in gene therapy with the biocluster GENOTHER

ART-TG is recruiting a head for its Bioproduction unit

La Ministre de la Recherche en visite à l'ART-TG. Focus sur la Thérapie Génique.

Oral presentation at ESGCT 22

Importance of standards in gene therapy

Time to Evolve: Predicting engineered T cell toxicity with next gen. models

ART-TG recruits

ASMA is laureate of BPI "Grand Défi - Biomédicaments"

HAPPY 2022

Visitez l'ART-TG pour la fête de la science 2021

Artificial Intelligence to improve the bioproduction of lentiviral gene therapy vectors.

ART-TG is a partner of the IRIS network of excellence (RHU) aiming to develop new generations...

ART-TG joints the T2Evolve European consortium

ART-TG welcomes the arrival of Gaele RIGAULT

L'ART-TG vous présente ses meilleurs voeux pour 2021

Colloque Pharmacité

HIV B-VAC project funded by ANRS

MAGENTA reçoit le label "Intégrateur Industriel"

Presentation of ART-TG at the Mabdesign Symposium